Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CENTER FOR FYSIOTERAPI & TRÆNING 2010 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.6% 3.9% 3.7% 3.4% 4.0% 2.8% 19.7% 19.7%   Credit score (0-100)   53 50 50 54 49 59 6 6   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,662 3,725 3,795 3,947 4,151 4,227 0.0 0.0   EBITDA   599 325 442 423 395 429 0.0 0.0   EBIT   529 252 369 363 354 424 0.0 0.0   Pre-tax profit (PTP)   726.0 455.7 570.4 560.1 621.4 712.4 0.0 0.0   Net earnings   601.5 391.6 482.6 478.8 540.6 618.4 0.0 0.0   Pre-tax profit without non-rec. items   726 456 570 560 621 712 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   253 179 106 46.2 5.3 0.0 0.0 0.0   Shareholders equity total   1,514 1,545 1,668 1,787 1,667 1,920 185 185   Interest-bearing liabilities   137 174 81.6 197 157 346 0.0 0.0   Balance sheet total (assets)   2,702 2,922 2,811 2,964 3,273 3,607 185 185   Net Debt   137 174 81.6 197 157 346 -185 -185     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,662 3,725 3,795 3,947 4,151 4,227 0.0 0.0   Gross profit growth   5.5% -20.1% 1.9% 4.0% 5.2% 1.8% -100.0% 0.0%   Employees   7 7 6 6 6 6 0 0   Employee growth %   0.0% 0.0% -14.3% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,702 2,922 2,811 2,964 3,273 3,607 185 185   Balance sheet change%   6.9% 8.2% -3.8% 5.4% 10.4% 10.2% -94.9% 0.0%   Added value   598.8 325.4 442.4 422.6 414.1 428.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -104 -146 -146 -120 -82 -11 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.3% 6.8% 9.7% 9.2% 8.5% 10.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.0% 16.3% 20.0% 20.6% 20.9% 21.9% 0.0% 0.0%   ROI %   45.3% 27.1% 33.0% 31.9% 34.2% 36.8% 0.0% 0.0%   ROE %   43.2% 25.6% 30.0% 27.7% 31.3% 34.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   56.0% 52.9% 59.3% 60.3% 50.9% 53.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   22.8% 53.4% 18.4% 46.7% 39.8% 80.8% 0.0% 0.0%   Gearing %   9.0% 11.2% 4.9% 11.0% 9.4% 18.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.3% 1.2% 2.8% 25.7% 16.9% 15.9% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.1 1.1 1.1 1.1 0.8 0.8 0.0 0.0   Current Ratio   1.1 1.1 1.1 1.1 0.8 0.8 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   169.6 166.2 92.8 79.5 -255.1 -284.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   86 46 74 70 69 71 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   86 46 74 70 66 71 0 0   EBIT / employee   76 36 62 60 59 71 0 0   Net earnings / employee   86 56 80 80 90 103 0 0